7/102 sources · 2 publishersUpdated Oct 29, 18:43 UTC
Guggenheim cuts Universal Health Services price target to $201
Guggenheim lowered its price target for Universal Health Services (UHS) to $201 from $209 while keeping a Buy rating. The revision follows a weak third‑quarter 2026 EBITDA result and slower ramp‑up at new facilities. UHS reported third‑quarter adjusted EPS of $5.22 and revenue of $4.73 billion, both slightly above estimates. The stock was trading around $172.18, down about 8.5% over the week.
Why it matters
The reduced target implies less upside for investors and may weigh on the share price, as the analyst notes weaker profit trends and a cautious 2027 outlook.
Key facts
- 1Guggenheim cut the price target to $201 from $209. investing.com
- 2UHS stock was trading at $172.18. investing.com
- 3UHS reported third‑quarter adjusted EPS of $5.22. investing.com
- 4UHS reported third‑quarter revenue of $4.73 billion. investing.com
- 5Guggenheim kept a Buy rating on UHS. tradingview.com
- 6The price‑target cut represents a 3.8% reduction. tradingview.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.